A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in Mexico
Teschemaker, A.R., Neslusan, C., Puig, A., Valencia, A., Johansen, P., Willis, M.Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.2057
Date:
November, 2013
File:
PDF, 80 KB
english, 2013